These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen. Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091 [TBL] [Abstract][Full Text] [Related]
24. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen. Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051 [TBL] [Abstract][Full Text] [Related]
25. Demonstration of monoclonal anti-carcinoembryonic antigen (CEA) antibody internalization by electron microscopy, western blotting and radioimmunoassay. Tsaltas G; Ford CH; Gallant M Anticancer Res; 1992; 12(6B):2133-42. PubMed ID: 1295459 [TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen. Kuroki M; Kuroki M; Koga Y; Matsuoka Y J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151 [TBL] [Abstract][Full Text] [Related]
27. Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives. Jackson H; Bacon L; Pedley RB; Derbyshire E; Field A; Osbourn J; Allen D Br J Cancer; 1998 Jul; 78(2):181-8. PubMed ID: 9683291 [TBL] [Abstract][Full Text] [Related]
28. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. Graff CP; Wittrup KD Cancer Res; 2003 Mar; 63(6):1288-96. PubMed ID: 12649189 [TBL] [Abstract][Full Text] [Related]
29. Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA. Kuroki M; Arakawa F; Khare PD; Kuroki M; Liao S; Matsumoto H; Abe H; Imakiire T Anticancer Res; 2000; 20(6A):4067-71. PubMed ID: 11131674 [TBL] [Abstract][Full Text] [Related]
30. Swine monoclonal antibodies of high affinity and specificity to carcinoembryonic antigen. Buchegger F; Fournier K; Schreyer M; Carrel S; Mach JP J Natl Cancer Inst; 1987 Aug; 79(2):337-42. PubMed ID: 2439734 [TBL] [Abstract][Full Text] [Related]
31. Production, purification and characterization of an anti-(carcinoembryonic antigen) recombinant single-chain Fv antibody fragment. Pérez L; Vázquez JE; Ayala M; Siccardi AG; Tresoldi E; de Lalla C; Gavilondo JV; Sidoli A Biotechnol Appl Biochem; 1996 Aug; 24(1):79-82. PubMed ID: 8756397 [TBL] [Abstract][Full Text] [Related]
32. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently. Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782 [TBL] [Abstract][Full Text] [Related]
33. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Hu S; Shively L; Raubitschek A; Sherman M; Williams LE; Wong JY; Shively JE; Wu AM Cancer Res; 1996 Jul; 56(13):3055-61. PubMed ID: 8674062 [TBL] [Abstract][Full Text] [Related]
34. Generation of a panel of related human scFv antibodies with high affinities for human CEA. Osbourn JK; Field A; Wilton J; Derbyshire E; Earnshaw JC; Jones PT; Allen D; McCafferty J Immunotechnology; 1996 Sep; 2(3):181-96. PubMed ID: 9373311 [TBL] [Abstract][Full Text] [Related]
35. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122 [TBL] [Abstract][Full Text] [Related]
36. Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody. Ford CH; Tsaltas GC; Osborne PA; Addetia K Cytometry; 1996 Mar; 23(3):228-40. PubMed ID: 8974868 [TBL] [Abstract][Full Text] [Related]
37. A multivalent recombinant antibody fragment specific for carcinoembryonic antigen. Perez L; Ayala M; Pimentel G; Bell H; Canaán-Haden L; Bequet M; González LJ; Miranda M; Ravelo R; Roque L; Acevedo B; Oliva JP; Gavilondo JV Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):39-48. PubMed ID: 16101587 [TBL] [Abstract][Full Text] [Related]
38. Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Sharkey RM; Goldenberg DM; Goldenberg H; Lee RE; Ballance C; Pawlyk D; Varga D; Hansen HJ Cancer Res; 1990 May; 50(9):2823-31. PubMed ID: 2328505 [TBL] [Abstract][Full Text] [Related]
39. Structural models for carcinoembryonic antigen and its complex with the single-chain Fv antibody molecule MFE23. Boehm MK; Perkins SJ FEBS Lett; 2000 Jun; 475(1):11-6. PubMed ID: 10854848 [TBL] [Abstract][Full Text] [Related]
40. Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones. Rodenburg CM; Mernaugh R; Bilbao G; Khazaeli MB Hybridoma; 1998 Feb; 17(1):1-8. PubMed ID: 9523232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]